The full U.S. House of Representatives will vote on an amendment to protect banks that service cannabis businesses from being penalized by federal regulators, a key committee decided on Tuesday. The House Rules Committee made in order the amendment to the National Defense Authorization Act (NDAA) for the fiscal year 2022, clearing it for floor consideration, which is expected later this week. Advocates are disappointed, however, that other cannabis and psychedelics reform measures were blocked by the panel. One stalled amendment would have promoted research into the therapeutic potential of certain psychedelics like psilocybin and MDMA for active-duty military members. Another would have codified that the U.S. Department of Veterans Affairs (VA) couldn’t deny home loan benefits to veterans just because they work in the cannabis industry. Last week, Rep. Lou Correa (D-CA) had filed a separate amendment to require VA to conduct a clinical trial into the therapeutic benefits of marijuana for veterans with chronic pain and post-traumatic stress disorder (PTSD), but the congressman withdrew it from consideration prior to an initial committee meeting on the defense legislation on Monday.

Kyle Jaeger, Marijuana Moment, 09/21/2021 22:15:00

Open article: